{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:37:19Z","timestamp":1770467839783,"version":"3.49.0"},"reference-count":97,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2015,9,2]]},"DOI":"10.1517\/13543784.2015.1057568","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T08:30:06Z","timestamp":1435653006000},"page":"1229-1239","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis"],"prefix":"10.1517","volume":"24","author":[{"given":"Jerzy","family":"Jaroszewicz","sequence":"first","affiliation":[{"name":"Medical University of Bia\u0142ystok, Department of Infectious Diseases and Hepatology","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Flisiak-Jackiewicz","sequence":"additional","affiliation":[{"name":"Medical University of Bia\u0142ystok, Department of Pediatrics, Gastroenterology & Allergology","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Lebensztejn","sequence":"additional","affiliation":[{"name":"Medical University of Bia\u0142ystok, Department of Pediatrics, Gastroenterology & Allergology","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Flisiak","sequence":"additional","affiliation":[{"name":"Medical University of Bia\u0142ystok, Department of Infectious Diseases and Hepatology","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12351"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22375"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12371"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12294"},{"key":"e_1_3_2_7_1","first-page":"344","article-title":"Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology","volume":"3","author":"Weiskirchen R","year":"2014","unstructured":"Weiskirchen R, Tacke F. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr 2014;3:344\u201363","journal-title":"Hepatobiliary Surg Nutr"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S9051"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI66028"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.003"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000155516.02468.0f"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.07.033"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2010.00718.x"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.04.008"},{"key":"e_1_3_2_15_1","doi-asserted-by":"crossref","unstructured":"Lorenzer C Dirin M Winkler AM et al. Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics. J Control Release 2015; 203C:1\u201315","DOI":"10.1016\/j.jconrel.2015.02.003"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.060129"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2009.05.010"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.014"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912766107"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00414.2010"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S43737"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2012.09.008"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1255351"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.05.007"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119964109"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2208"},{"key":"e_1_3_2_27_1","unstructured":"EASL Recommendations on Treatment of Hepatitis C 2014. Available from: http:\/\/files.easl.eu\/easl-recommendations-on-treatment-of-hepatitis-C\/index.html"},{"key":"e_1_3_2_28_1","unstructured":"AASLD-IDSA recommendations for testing managing and treating hepatitis C. 2014. Available from: http:\/\/www.hcvguidelines.org\/full-report-view"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-014-0372-6"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.02.029"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20736"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21669"},{"key":"e_1_3_2_34_1","unstructured":"Available from: http:\/\/www.hepatitisc.uw.edu\/page\/clinical-calculators"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20772"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.8352"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20717"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-012-0307-z"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365520510015674"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-7-40"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.048389"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20935"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21835"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.05.035"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.018"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1335205"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2013.02.011"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.03.016"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25936"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.02.017"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12395"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61425-1"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07124-4"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33023"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.05.044"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.11.050"},{"key":"e_1_3_2_58_1","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.12382","article-title":"Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis","author":"Haseltine EL","year":"2015","unstructured":"Haseltine EL, Penney MS, George S, et al. Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis. J Viral Hepat 2015. [Epub ahead of print]","journal-title":"J Viral Hepat"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316366"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402869"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1371010"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1371009"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2014.929497"},{"issue":"1","key":"e_1_3_2_64_1","first-page":"1962","article-title":"Trends in liver fibrosis testing, hepatic synthetic function, and platelet counts at baseline and 12 weeks after treatment with ABT-450\/r\/ombitasvir and dasabuvir with ribavirin in HCV genotype 1-infected patients with cirrhosis","volume":"60","author":"Shiffman ML","year":"2014","unstructured":"Shiffman ML, Kowdley KV, Poordad F, et al. Trends in liver fibrosis testing, hepatic synthetic function, and platelet counts at baseline and 12 weeks after treatment with ABT-450\/r\/ombitasvir and dasabuvir with ribavirin in HCV genotype 1-infected patients with cirrhosis. Hepatology 2014;60(Suppl 1):1962","journal-title":"Hepatology"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)31011-4"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30015-5"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30167-7"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12576"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.144878"},{"key":"e_1_3_2_70_1","article-title":"Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014","author":"Torok NJ","year":"2015","unstructured":"Torok NJ, Dranoff JA, Schuppan D, et al. Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014. Hepatology 2015; Epub ahead of print","journal-title":"Hepatology"},{"key":"e_1_3_2_71_1","article-title":"Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats","author":"Hsu SJ","year":"2014","unstructured":"Hsu SJ, Lee FY, Wang SS, et al. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats. Hepatology 2014. [Epub ahead of print]","journal-title":"Hepatology"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27054"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-014-2302-1"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04503.x"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840380412"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12090"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25804"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.038"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27392"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.07.018"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12570"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.227"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3282"},{"key":"e_1_3_2_85_1","article-title":"Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance","author":"Seguin L","year":"2015","unstructured":"Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol 2015. [Epub ahead of print]","journal-title":"Trends Cell Biol"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00001111"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.107136"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-14-131"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.12.050"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.02.081"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00162.2009"},{"issue":"1","key":"e_1_3_2_93_1","first-page":"423A","article-title":"rbesartan for severe fibrosis in chronic hepatitis C: a double-blind randomized trial (ANRS HC19 Fibrosar)","volume":"60","author":"Cales P","year":"2014","unstructured":"Cales P, Bacq Y, Vine JP, et al. rbesartan for severe fibrosis in chronic hepatitis C: a double-blind randomized trial (ANRS HC19 Fibrosar). Hepatology 2014;60(Suppl 1):423A","journal-title":"Hepatology"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25938"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.05.007"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1396"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301746"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2014.07.003"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(13)60598-X"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.2015.1057568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T18:24:28Z","timestamp":1770402268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.2015.1057568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,30]]},"references-count":97,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9,2]]}},"alternative-id":["10.1517\/13543784.2015.1057568"],"URL":"https:\/\/doi.org\/10.1517\/13543784.2015.1057568","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-06-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}